Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Total Non-Current Liabilities (2021 - 2025)

Historic Total Non-Current Liabilities for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to $250.5 million.

  • Roivant Sciences' Total Non-Current Liabilities fell 218.73% to $250.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $250.5 million, marking a year-over-year decrease of 218.73%. This contributed to the annual value of $18.4 million for FY2025, which is 1995.83% up from last year.
  • Latest data reveals that Roivant Sciences reported Total Non-Current Liabilities of $250.5 million as of Q4 2025, which was down 218.73% from $257.0 million recorded in Q3 2025.
  • Over the past 5 years, Roivant Sciences' Total Non-Current Liabilities peaked at $814.4 million during Q2 2022, and registered a low of $15.4 million during Q1 2024.
  • Its 5-year average for Total Non-Current Liabilities is $508.1 million, with a median of $560.5 million in 2021.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first soared by 7450.12% in 2022, then plummeted by 9799.25% in 2024.
  • Roivant Sciences' Total Non-Current Liabilities (Quarter) stood at $521.4 million in 2021, then skyrocketed by 44.66% to $754.3 million in 2022, then decreased by 4.07% to $723.7 million in 2023, then crashed by 64.62% to $256.1 million in 2024, then fell by 2.19% to $250.5 million in 2025.
  • Its Total Non-Current Liabilities was $250.5 million in Q4 2025, compared to $257.0 million in Q3 2025 and $216.5 million in Q2 2025.